AVE 0.00% 0.3¢ avecho biotechnology limited

new ceo and board 'business model', page-54

  1. 5,322 Posts.
    Suds can you tell me what date POH Ann d the. COO appointment - I can't see it listed .

    As for future of Oxy programs - it's all laid out in the last 2 Pain Ann's . Why are you suggesting delays? The OxyM multi dose trial results were actually ahead of schedule .

    As for the CEO appointment . POHs timeline is its own . The recruitment of a CEO is a little more complex than hiring a receptionist ( which can be done in a fortnight). Lots of due diligence - multiple interviews - discussion at Board level then finally a candidate is chosen and an offer made . Then comes the negotiation on package and finally the contract is drafted, then submitted to the candidate who gives it to his/ her lawyer to vet and so the journey goes on until POH has a signature . Only then can the appointment be Annd and even that may be delayed depending on the appointees current employment arrangements . So your comment that POH is happy to have the CEO chair empty is a bit naive .
    COO ? We may not need one.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.32K 440K

Buyers (Bids)

No. Vol. Price($)
30 40522233 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40066709 32
View Market Depth
Last trade - 14.05pm 15/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.